Skip to content
healthcare.dev

Nilotinib

NDC 69097-030, Nilotinib, capsule, from Cipla USA Inc..

Product NDC
69097-030
Status
Listed
Labeler
Cipla USA Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA218922
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69097-030 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NILOTINIB50 mg/1

Pharmacologic classes

Bcr-Abl Tyrosine Kinase Inhibitors [MoA]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C8 Inducers [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Kinase Inhibitor [EPC]; P-Glycoprotein Inhibitors [MoA]; UGT1A1 Inhibitors [MoA]

Package NDCNDC-11Package
69097-030-0869097003008120 CAPSULE in 1 BOTTLE, PLASTIC (69097-030-08)
69097-030-63690970030637 BLISTER PACK in 1 CARTON (69097-030-63) / 4 CAPSULE in 1 BLISTER PACK (69097-030-16)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e27c3e09-bc4f-4f01-be05-1c43ac72285d

Use it

Look up 69097-030 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69097-030 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69097-030. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.